Abubacar, Pikaw L.

HRN: 14-63-73  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/27/2022
CEFUROXIME 1.5GM (VIAL)
07/27/2022
08/03/2022
IV
1.5gm
Q8
Non Healing Wound
Waiting Final Action 
07/27/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/27/2022
08/03/2022
IV
600mg
Q6
Non Healing Wound
Waiting Final Action 
07/28/2022
CEFTAZIDIME 1GM (VIAL)
07/28/2022
08/03/2022
IV
1g
Q8
DM Foot
Waiting Final Action 
08/02/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/02/2022
08/09/2022
IV
1.5G
OD
Dm Foot

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: